Interface Pharmaceuticals Pvt Ltd - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 1999.
1999 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Interface Pharmaceuticals Pvt Ltd

Interface Pharmaceuticals Pvt Ltd, a active private limited company, was established on 14 June 1999 in New Delhi, Delhi, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24232DL1999PTC100229. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Sudhir Kumar Malhotra (Director), Shilpa Malhotra (Director), Promila Malhotra (Director). Past directors included Manan Malhotra. It holds ₹7.95 M open charges and ₹1.55 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Ea-180, Maya Enclave, New Delhi, Delhi, 110064.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL1999PTC100229

  • Registration Number

    100229

  • Incorporation Date

    14 June 1999

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 26 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 7.95 M
  • Satisfied Charges ₹ 1.55 M
  • Revenue Growth **** 57.91%
  • Profit Growth **** 98.90%
  • Ebitda **** 79.08%
  • Net Worth 53.51%
  • Total Assets **** 43.08%
Company report

Interface Pharmaceuticals Pvt Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Interface Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Interface Pharmaceuticals Pvt Ltd?
Current Directors
Name Designation Appointment Date Status
Sudhir Kumar Malhotra Director 14 Jun 1999 Current
Shilpa Malhotra Director 20 Oct 2019 Current
Promila Malhotra Director 14 Jun 1999 Current
Manan Malhotra Director 25 Jul 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 28 Mar 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Interface Pharmaceuticals.

Interface Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 57.91% increase. The company also saw a substantial improvement in profitability, with a 98.9% increase in profit. The company's net worth Soared by an impressive increase of 53.51%.

Interface Pharmaceuticals revenue growth over time
Interface Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 57.91%
*******
*******
*******
*******
Revenue from Operations
*******
 57.89%
*******
*******
*******
*******
Total Assets
*******
 43.08%
*******
*******
*******
*******
Profit or Loss
*******
 98.90%
*******
*******
*******
*******
Net Worth
*******
 53.51%
*******
*******
*******
*******
EBITDA
*******
 79.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Interface Pharmaceuticals?

In 2022, Interface Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹7,950,000.00

Satisfied Charges

₹1,550,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.80 Cr
Latest Charge Details
Date Lender Amount Status
18 Sep 2023 Hdfc Bank Limited ₹7.95 M Open
22 Nov 2008 The Nainital Bank Limited ₹0.90 M Satisfied
20 Sep 2004 The Nainital Bank ₹0.65 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Interface Pharmaceuticals?

Unlock and access historical data on people associated with Interface Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Interface Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Interface Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Interface Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Interface Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Interface Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 7.95 M with Charge ID 100820948 was registered on 18 Sep 2023. was documented.

  • Charges

    Progress on A charge registered on 22 Nov 2008 via Charge ID 10132572 with The Nainital Bank Limited was fully satisfied on 15 Sep 2022. was documented.

  • Director Appointment

    Progress on Manan Malhotra was appointed as a Director was appointed as a Director on 25 Jul 2022 & has been associated with this company since 3 years 6 months . was documented.

  • Director Appointment

    The activity Shilpa Malhotra was appointed as a Director was appointed as a Director on 20 Oct 2019 & has been associated with this company since 6 years 3 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Interface Pharmaceuticals Pvt Ltd?

The CIN of Interface Pharmaceuticals Pvt Ltd is U24232DL1999PTC100229.

Where is Interface Pharmaceuticals Pvt Ltd headquartered?

Interface Pharmaceuticals Pvt Ltd is headquartered at Ea-180, Maya Enclave, New Delhi, Delhi, 110064.

When was Interface Pharmaceuticals Pvt Ltd incorporated?

Interface Pharmaceuticals Pvt Ltd was incorporated on 14 June 1999.

Who are the current directors of Interface Pharmaceuticals Pvt Ltd?

The current directors of Interface Pharmaceuticals Pvt Ltd are

What is the primary industry of Interface Pharmaceuticals Pvt Ltd?

The primary industry of Interface Pharmaceuticals Pvt Ltd is Manufacturing.

Is Interface Pharmaceuticals Pvt Ltd a listed company?

Interface Pharmaceuticals Pvt Ltd is unlisted.

What is the capital structure of Interface Pharmaceuticals Pvt Ltd?

The authorized capital of Interface Pharmaceuticals Pvt Ltd is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Interface Pharmaceuticals Pvt Ltd?

The compliance status of Interface Pharmaceuticals Pvt Ltd is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available